Vortioxetine eases depression in older adults, while cognitive gains stay mixed—showing selective boosts in attention and processing speed, not consistent global improvement.
Ibrahim Makki, MD
Advertisement
Dr Makki is a psychiatrist at St. Joseph’s Health Care London, and an assistant professor in the geriatric department of Schulich School of Medicine & Dentistry at Western University.
Articles by Ibrahim Makki, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Defining Treatment-Resistant Depression In Adults
2
Interventional Options for TRD: ECT, TMS, and Esketamine
3
ARFID: When Remission Is Not Silence
4
FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia
5